News

Less than half of affected patients (42.86%) indicated previous history of conjunctivitis prior to initiating dupilumab treatment.

Biologic use was not associated with an increased risk of hepatitis B virus flares.

Metabolomic and preclinical studies have indicated that branched-chain amino acids may protect against neurodegenerative diseases.

Roughly 60% of participants in the SINUS-24 and SINUS-52 trials reported improvements in the severity of loss-of-taste.

Data show both microvascular and macrovascular outcomes were significantly improved following bariatric intervention in patients with obesity.

Patients with IBD have an increased risk of developing a C difficile infection in comparison to the general population.

More than 56% of these patients enrolled in TARGET-NASH were being treated with statins.

Researchers in the UK recommend early detection and treatment of food allergy and sensitization to avoid complications in adulthood.

While the nerve disease is not life threatening, patients may experience considerable poor quality of life and emotional distress.

About 25% of IBD patients with CDI had a history of antibiotic use.

A new report sheds light on the gaps in knowledge and research surrounding the reproductive health of girls and women with sickle cell disease.

Dr. Jorge Maspero speaks of the complications of severe chronic rhinosinusitis with nasal polyps and how dupilumab could improve the daily struggles patients face.

There are several cholesterol lowering drugs available for this patient population.

Retinal laser photocoagulation may be performed by a specialist from a distance using telemedicine platforms.

One theory as to why IBD patients are more susceptible to CDI is the use of immunosuppressant treatments.

Despite a global decrease in asthma deaths, researchers say the disease is particularly threatening to patients with atopic dermatitis.

This edition of HCPLive® State of the Science involves 3 experts discussing different trends in IBD treatments and care.

Dr. Jorge Maspero speaks of the recent successes of the two newest trials, and what they could mean for the future of chronic rhinosinusitis management.

Adults who have received at least one prior line of therapy may receive daratumumab and hyaluronidase-fihj combined with pomalidomide and dexamethasone.

The virtual sessions will cover a litany of topics in the greater spectrum of cardiovascular disease prevention and care.

Data show SGLT2is reduced HHF in patients with both stablished HFrEF and CKD and are likely to also be effective in patients with HFpEF.

With approval on July 9, finerenone (Kerendia) becomes the first nonsteroidal mineralocorticoid receptor antagonist to receive approval for use in adults with chronic kidney disease associated with type 2 diabetes.

According to 3x3 mm and 6x6 mm OCTA scans, there were no significant changes in mean macular intercapillary area measures for all tested regions.

96.4% of patients in symptomatic remission at week 152 were corticosteroid-free.

Several different treatments appear to be efficacious in this patient population.

A variety of online drowning prevention resources can be accessed by parents and health care professionals, promoting safe swimming in the summer.

Researchers found the strongest associations between ADHD and nervous system disorders and respiratory diseases.

Data from COMPASS show adding low-dose low-dose rivaroxaban to aspirin resulted in benefits regardless of number of concomitant drugs or comorbidities.